We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sugar-Coated Proteins Trigger Insulin Resistance

By Biotechdaily staff writers
Posted on 24 May 2002
Newly published research shows that intracellular glycosylation of proteins may initiate insulin resistance, a key feature of diabetes. More...
The report in the April 16, 2002, issue of the Proceedings of the National Academy of Sciences describes how proteins involved in the insulin pathway fail to work properly after becoming coated with too many sugar molecules.

Type 2 diabetes, the most common form in adults, occurs when muscle, fat and other tissues stop responding to insulin's signals to remove excess sugar from the blood. "Cells do not respond to insulin itself. Instead, a whole cascade of events, set in motion by insulin, eventually causes cells to take in sugar,” explains Dr. Gerald Hart of Johns Hopkins University (Baltimore, MD, USA; www.jhu.edu). "We now have an explanation of how sugar can affect these signals, and even a hypothesis for how high blood sugar could cause tissue damage in diabetes--by improperly modifying proteins.”

The research team developed new methods for analyzing simple sugars with special emphasis on O-linked beta-N-acetylglucosamine (O-GlcNAc), which is frequently used by the cell nucleus and protoplasm to label proteins and modify their behavior. In the current study, the scientists employed a blocker called PUGNAc to force the glycosylation of cellular proteins without adding extra sugar, as had been done by others to create insulin resistance.

Not only did the blocker increase the amount of O-GlcNAc bound to proteins, but also the increase caused the cells to stop responding to insulin. Two proteins from the insulin-signaling pathway, beta-catenin and insulin receptor substrate-1 (IRS-1), were found to be more glycosylated than normal. The researchers suspect that the ability of these proteins to function is adversely affected by the extra sugars they carry. Thus, increasing O-GlcNAc on proteins is, by itself, a cause of insulin resistance, rather than an effect or a coincidence.



Related Links:
Johns Hopkins University

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.